Literature DB >> 28876065

Carbon Monoxide and Its Controlled Release: Therapeutic Application, Detection, and Development of Carbon Monoxide Releasing Molecules (CORMs).

Ken Ling1,2, Fang Men3, Wei-Ci Wang4, Ya-Qun Zhou5, Hao-Wen Zhang1, Da-Wei Ye1.   

Abstract

Carbon monoxide (CO) is attracting increasing attention because of its role as a gasotransmitter with cytoprotective and homeostatic properties. Carbon monoxide releasing molecules (CORMs) are spatially and temporally controlled CO releasers that exhibit superior and more effective pharmaceutical traits than gaseous CO because of their chemistry and structure. Experimental and preclinical research in animal models has shown the therapeutic potential of inhaled CO and CORMs, and the biological effects of CO and CORMs have also been observed in preclinical trials via the genetic modulation of heme oxygenase-1 (HO-1). In this review, we describe the pharmaceutical use of CO and CORMs, methods of detecting CO release, and developments in CORM design and synthesis. Many valuable clinical CORMs formulated using macromolecules and nanomaterials are also described.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28876065     DOI: 10.1021/acs.jmedchem.6b01153

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  27 in total

1.  Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials.

Authors:  Roy Weinstain; Tomáš Slanina; Dnyaneshwar Kand; Petr Klán
Journal:  Chem Rev       Date:  2020-10-30       Impact factor: 60.622

2.  Photoactivated in Vitro Anticancer Activity of Rhenium(I) Tricarbonyl Complexes Bearing Water-Soluble Phosphines.

Authors:  Sierra C Marker; Samantha N MacMillan; Warren R Zipfel; Zhi Li; Peter C Ford; Justin J Wilson
Journal:  Inorg Chem       Date:  2018-01-11       Impact factor: 5.165

3.  Classification of Metal-based Drugs According to Their Mechanisms of Action.

Authors:  Eszter Boros; Paul J Dyson; Gilles Gasser
Journal:  Chem       Date:  2019-11-07       Impact factor: 22.804

4.  Towards "CO in a pill": Pharmacokinetic studies of carbon monoxide prodrugs in mice.

Authors:  Minjia Wang; Xiaoxiao Yang; Zhixiang Pan; Yingzhe Wang; Ladie Kimberly De La Cruz; Binghe Wang; Chalet Tan
Journal:  J Control Release       Date:  2020-08-01       Impact factor: 9.776

5.  CatroxMP-II: a heme-modulated fibrinogenolytic metalloproteinase isolated from Crotalus atrox venom.

Authors:  Montamas Suntravat; Paul R Langlais; Elda E Sánchez; Vance G Nielsen
Journal:  Biometals       Date:  2018-05-14       Impact factor: 2.949

Review 6.  Carbon monoxide: An emerging therapy for acute kidney injury.

Authors:  Xiaoxiao Yang; Mark de Caestecker; Leo E Otterbein; Binghe Wang
Journal:  Med Res Rev       Date:  2019-12-09       Impact factor: 12.944

7.  H2S attenuates oxidative stress via Nrf2/NF-κB signaling to regulate restenosis after percutaneous transluminal angioplasty.

Authors:  Ken Ling; Wei Zhou; Yi Guo; Guofu Hu; Jie Chu; Fen Xie; Yiqing Li; Weici Wang
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-30

Review 8.  Carbon Monoxide and Nitric Oxide as Examples of the Youngest Class of Transmitters.

Authors:  Alicja Nowaczyk; Magdalena Kowalska; Jacek Nowaczyk; Grzegorz Grześk
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

9.  Evaluating the effects of carbon monoxide releasing molecule-2 against myocardial ischemia-reperfusion injury in ovariectomized female rats.

Authors:  Arthi Kumar; Sri Rahavi Boovarahan; Priyanka N Prem; Meenakshi Ramanathan; David Raj Chellappan; Gino A Kurian
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-08-02       Impact factor: 3.000

Review 10.  Significance of Heme and Heme Degradation in the Pathogenesis of Acute Lung and Inflammatory Disorders.

Authors:  Stefan W Ryter
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.